Latest Kaiser Health News Stories
Ride-sharing companies promise better service for enrollees and lower costs for states. But the services are not for everyone on Medicaid.
Naltrexone, commonly used for opioid and alcohol use disorders, may also help patients with chronic pain — when prescribed in low doses. But few doctors or patients seem to know about it.
Without the teamwork, communication and quick action of several veteran health officials in Wisconsin, the world might not know about the vaping illness the U.S. is battling today. This is their story.
The House speaker announced her plan for lowering drug prices, which includes negotiations between drugmakers and federal health officials.
Programs for health care professionals addicted to opioids generally bar a proven recovery method: the use of drugs like buprenorphine and methadone to relieve cravings.
Barbara Van Rooyan lost her son to the drug 15 years ago and has fought ceaselessly since then to hold Purdue Pharma accountable for its role in the opioid crisis.
State regulators and even one medevac company have raised doubts about prepaid subscriptions and promised benefits offered by air ambulance companies.
But critics say the new policy still leaves some patients exposed to lawsuits and crippling bills.
KHN reported this week that the University of Virginia Health System has filed 36,000 lawsuits against patients the past six years.
In the first six months of this year, pharmaceutical firms and their trade groups donated almost $4 million to the campaigns of a variety of senators and House members.
As lobbyists purporting to represent doctors and hospitals fight attempts to control surprise medical bills, it has become increasingly clear that the force behind the effort is not just medical professionals, but also investors from private equity firms.
A Kaiser Health News investigation, which first appeared in The Washington Post, showed that the University of Virginia Health System has sued patients 36,000 times for more than $106 million.
Over six years, the state institution filed 36,000 lawsuits against patients seeking a total of more than $106 million in unpaid bills, a KHN analysis finds.
A long-awaited class-action lawsuit against Sutter is set to open this month in San Francisco Superior Court. The hospital giant stands accused of violating California’s antitrust laws by leveraging its market power to drive out competition and overcharge patients.
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don’t have to.
Groupon and other deal sites are the latest marketing tactic in medicine, offering bargain prices but potentially unnecessary, duplicative services.
KHN’s Sarah Varney discussed opioid painkillers in India with NPR’s Rachel Martin on “Morning Edition” Thursday.
It’s easy to criticize pharmaceutical and insurance companies. But we spend much more on hospitals.
New research published in JAMA Network Open quantified for the first time international differences in doctors’ prescribing habits and patients’ use of these highly addictive painkillers.
A proposed state law would require on-campus health centers to provide students with the medicines that allow them to end an unwanted pregnancy. Former Gov. Jerry Brown vetoed a similar bill last year, but Gov. Gavin Newsom has said he would sign it.